StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Catalyst Pharmaceutical Partners, Incorporated

Enter Symbol or Keywords

Two Year Low in Free Cash Flow for Catalyst Pharmaceutical Partners

Stock Quote: (NCM:CPRX)

11/20/2009

0.63

+0.0299

+4.98%

179,055

Two Year Low in Free Cash Flow for Catalyst Pharmaceutical Partners

Last

Price Change

% Chg

Volume

New York, NY, November 20, 2009-Free-Cash-News reports that negative Free Cash Flow for Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) for its twelve months ended September 30, 2009 was $(9,754, ... read full story

Website Address:	www.catalystpharma.com
Industry:	Generic Pharmaceuticals

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: CPRX

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: CPRX

11/24/2009

EBITDA Improves 56% for Catalyst Pharmaceutical Partners

11/20/2009

OPS Ranking of "8" for Catalyst Pharmaceutical Partners Reiterated by StockDiagnostics.com

11/20/2009

Two Year Low in Free Cash Flow for Catalyst Pharmaceutical Partners

... more CPRX exclusives

Other News Sources: CPRX

11/13/2009

Catalyst Receives Guidance from Nasdaq Regarding Minimum Bid Price Requirement

11/12/2009

/C O R R E C T I O N -- Catalyst Pharmaceutical Partners, Inc./

11/10/2009

U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain

... more CPRX news from other sources

Daily Market Updates

02/09/2010

Markets Close Day After Strong Rally as Concerns Ease re Greece

Stocks closed today's strong rally following speculation that the European Union will step in to bail out Greece. Germany and its European Union partners are expected to offer Greece and other troubled EU members loan guarantees. Oil climbed almost $ ... read full story